3.3400
-0.0400
(-1.18%)
At close: January 10 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-5,620.0000
-7,092.0000
-8,183.0000
-7,899.0000
-17,203.0000
Investing Cash Flow
504.0000
732.0000
--
-23.0000
-540.0000
Financing Cash Flow
406.0000
10,000.0000
4,984.0000
8,841.0000
17,933.0000
End Cash Position
3,399.0000
6,773.0000
3,133.0000
6,332.0000
5,413.0000
Interest Paid Supplemental Data
30.0000
21.0000
--
--
295.0000
Capital Expenditure
--
-2.0000
--
-23.0000
-540.0000
Issuance of Capital Stock
406.0000
9,500.0000
4,980.0000
8,841.0000
11,636.0000
Issuance of Debt
--
750.0000
--
--
654.0000
Repayment of Debt
--
-250.0000
--
--
-1,600.0000
Free Cash Flow
-5,622.0000
-7,094.0000
-8,183.0000
-7,922.0000
-17,743.0000
12/31/2020 - 1/18/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVTE Aerovate Therapeutics, Inc.
2.5500
-3.41%
CHRO Channel Therapeutics Corporation
0.9026
-10.64%
MDG1.F Medigene AG
1.0120
+0.20%
2H51.HM Ocugen Inc
0.7625
-8.13%
CVAC.VI CureVac N.V.
4.2600
+8.78%
ALZN Alzamend Neuro, Inc.
1.1300
-0.88%
TCRT Alaunos Therapeutics, Inc.
1.7000
-6.59%
CRVO CervoMed Inc.
2.1100
-3.21%
HESG Health Sciences Group, Inc.
0.0000
0.00%
ESLA Estrella Immunopharma, Inc.
1.1900
+6.25%